Connect public, paid and private patent data with Google Patents Public Datasets

Phenoxyacetic acid derivatives and preparation thereof

Info

Publication number
CA1277675C
CA1277675C CA 543552 CA543552A CA1277675C CA 1277675 C CA1277675 C CA 1277675C CA 543552 CA543552 CA 543552 CA 543552 A CA543552 A CA 543552A CA 1277675 C CA1277675 C CA 1277675C
Authority
CA
Grant status
Grant
Patent type
Prior art keywords
group
mixture
ethyl
ml
cm
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA 543552
Other languages
French (fr)
Inventor
Takayuki Kawaguchi
Takeo Iwakuma
Toyoharu Yamashita
Yasuhiko Sasaki
Tamotu Shimazaki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tanabe Seiyaku Co Ltd
Original Assignee
Tanabe Seiyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Grant date

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/15Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings

Abstract

Abstract:
The present invention is directed to novel phenoxyacetic acids of the formula:

(I) wherein Ring A is a phenylene group or a phenylene group having 1 or 2 substituents selected from a lower alkyl group, a lower alkoxy group and a halogen atom; either one or two groups of R1, R2, R3 and R4 are a lower alkyl group, and the other groups are hydrogen atoms;
R5 is a phenyl group or a phenyl group having 1 to 3 substituents selected from a lower alkyl group, a halogen atom, a lower alkoxy group, a trihalogenomethyl group, and a nitro group; and -COOR6 is a carboxyl group or a protected carboxyl group, or pharmaceutically accept-able salts thereof. The compounds of formula (I) and salts thereof have potent platelet aggregation-inhibiting activity.

Description

~'~J~'7~ ~

Phenoxyacetic acld derivatives and preparation thereof This invention relates to novel phenoxyacetic acid compounds and processes for preparing same. More particular].y, it relates to phenoxyacetic acid compounds of the formula.

R S02NH ~ ~ OCH2COOR6 (I) wherein Ring A is a phenylene group or a phenylene group having 1 or 2 substituents selected from a lower alkyl group, a lower alkoxy group and a halogen atom; either one or two groups of Rl, R , R and R are a lower alkyl group, and the other groups are hydrogen atoms; R5 is a phenyl group or a phenyl group having 1 to 3 subs-tituents selected from a lower alkyl group, a halogen atom, a lower alkoxy group, a trihalogenomethyl group and nitro group; and -COOR6 is a carboxyl group or a protected carboxyl group, or pharma-ceutically acceptable salts thereof.

~-~t7 The phenoxyacetic acid compounds tI) show potent platelet aggregation-inhibiting activity and are useful in the treatment and/or prophylaxis of thrombotic diseases.
Examples of the compounds of the present invention are those of the formula (I) in which Ring A is a phenylene group or a phenylene group having 1 to 2 substituents selected from an alkyl group of one to four carbon atoms, e.g., methyl, ethyl, propyl or butyl, an alkoxy group of one to three carbon atoms, e.g., methoxy, ethoxy or propoxy and a halogen atom, e.g., chlorine, bromine or fluorine;
either one or two groups of R to R4 are an alkyl group of one to four carbon atoms, e.g., methyl, ethyl, propyl or butyl, and the other groups of Rl to R4 are hydrogen atoms;
R is a phenyl group or a phenyl group having 1 to 3 lS su~stituents selected from the class consisting of an alkyl group of one to three carbon atoms, e.g., methyl, ethyl or propyl, a halogen atom, e.g., fluorine, chlorine or bromine, an alkoxy group of one to three carbon atoms; e.g., methoxy, ethoxy or propoxy, a trihalogenomethyl group, e.g., trifluoromethyl and a nitro group; and -COOR6 is a carboxyl group which may be optionally protected with a protecting group, e.g., an alkyl group of one to three carbon atoms (e.g., methyl, e-thyl or propyl) or a substituted or un-substituted phenyl-alkyl group of 7 to 13 carbon atoms (e.g., benzyl, p-methoxybenzyl, p-nitrobenzyl or benzhydryl).
Amony them, preferred examples of the compounds of the invention are those of the formula (I) in which Ring A
is a phenylene group or a phenylene group having 1 to 2 76~7S

substituents selected from an alkyl group of one to three carbon a-toms, a halogen atom and an alkoxy group of one to three carbon atoms; either one or two groups of Rl to R are an alkylgroup of one to four carbon atoms, and the other groups of Rl to R are hydrogen atoms; R5 is a phenyl group or a phenyl group having l to 3 substi.tuents selected from an alkyl group of one to three carbon atoms, a halogen atom, an alkoxy group of one to three carbon atoms, a trihalogenomethyl group and a nitro group; and -COOR6 is free carboxyl group or a carboxyl group protected with an alkyl group of one to three carbon atoms. Other preferred examples of the compounds of the invention are those of the formula (I) in which Ring A is a phenylene group or a phenylene group substituted with a halogen atom; either one o Rl to ~4 is an alkyl group of one to four carbon atoms, and the other groups of R1 to R4 are hydrogen atoms;
R is a phenyl group ox a phenyl group substituted with an alkyl group of one to three carbon atoms, a halogen atom, a trihalogenomethyl group or a nitro group; and -COOR6 is a free carboxyl group or a carboxyl group pro-tected with an alkyl group of one to three carbon atoms.
Other preferred examples of the compounds of the invention are those of the formula (I) in which Ring A is a phenylene group or a phenylene group substit,uted with a fluorine atom or chlorine atom; either one of Rl to R4 is a methyl group or an ethyl group, and the other groups are hydrogen atoms;
R~ is a phenyl group or a phenyl group substituted with a t7~6~7:~

methyl group, a chlorine atom, a bromine atom, a trifluoromethyl group or a nitro group; and -COOR6 is a free carboxyl group or a carboxyl group protected with an alkyl group of one to ~hree carbon atoms.
While the compound of formula (I) may exist in the form of two optically active isomers or in the form of two stereo isomers or four optically active isomers due to one or two asymmetric carbon atoms, the present in-vention includes within its scope all of these isomers and mixtures thereof.
According to the present invention, the compound of formula (I) or a sal~ thereof can be prepared by:
i) condensing a phenol compound of the formula:

R SO2NH - ~ ~ OH (II) wherein Ring A, R , R , R , R and R are the same as defined above, or a salt thereof with an acetic acid derivative of the formula:

X C~12COOR (III) whexein Xl is a reactive residue and -COOR6~ is a carboxyl group or a protec-ted carboxyl group, ~'7 ii) when -COOR61 is a protected carboxyl ~roup, optionally removing said protecting group therefrom, and iii) if required, further converting the product into a salt thereof.
Alternatively, the compound of formula (I) or a sal-t thereof can be prepared by:
i) condensing a phenoxyacetic acid derivative of the formula:

Y~ f _~ OCH2COOR (IV) w-herein Y is an amino group, a protected amino group or a reactive ~esidue, a Ring A, R ~ R , R , R and -COOR
are the same as defined above, or a salt thereof with a benzenesulfonic acid compound of the formula:

R5So2Z (V) wherein Z is a hyd-roxy group or a reactive residue when Y is an amino group or a protected amlno group, or Z is an amino group when Y is a reactive residue, and R is the same as defined above, ii) when -COOR61 is a protected carboxyl group and/or Y is a protected amino group, optionally removing said protecting group or groups therefrom, and '76~.~

iii~ if required, further converting the product into a salt thereof.
Any protecting groups, which can be readily removed in a conventional manner, e.g., hydrolysis, acid-treatment and reduction, may be used to protect the carboxyl group of the starting compounds (III) and (IV). Examples of such protecting groups li.e., the group R61) include, for example, a lower alkyl group, e.g., methyl, ethyl, propyl or butyl, and a substituted or unsubstituted phenyl-lower alkyl group, e.g., benzyl, p-methoxybenzyl, p-nitrobenzyl or benzhydryl. Examples of the reactive residue X and Y or Z include a h-alogen atom, e.g., chlorine, bromine or iodine, a lower alkylsulfonyloxy group, e.g., methanesulfonyloxy, a substituted or unsubstituted phenyl-sulfonyloxy group, e.g., benzenesulfonyloxy or p-toluene-sulfonyloxy, and the like.
The condens-ation of the starting compounds (II) and (LIl) can be readily conducted in an inert solvent.
Acetone, chloroform, lower alkanols, methylene chloride, tetrahydrofuran, dimethyl sulfoxide, dimethylformamide and a mixture -thereof are suitable as the solvent. In carrying out the reaction, the phenol compound (II) may be used in the form of a salt, e.g., an alkali metal salt, an alkaline earth metal salt and the like. It is preferred to carry out the reaction in the presence of an acid acceptor, e.g., an alkali metal carbonate, an alkali metal oxide, an alkali metal bicarbonate and 7~it75 an organic amine (e.y., triethylamine). It is also preferred to carry it out at a temperature of 20 to 100 C.
The condensation of the starting compounds (IV) and (V) can be conducted in the presence of an acid acceptor with or without a solvent. Examples of the acid acceptor include an alkali metal bicarbonate, an alkali metal carbonate, an alkaline earth metal carbonate, and organic bases, e.g., pyridine, trimethylamine or triethylamine.
Ether, benzene, methylene, chloride, dioxane, ethanol, methanol, water and a mixture thereof are suitable as the solvent. The compound (IV) in which Y is an amino group may be used for the reaction in the form of an organic or inorganic acid addition s-alt e.g., hydrochloride, hydrobromide, methanesulfonate, oxalate and the like; or the compound (IV) in which Y is a protected amino group and/or -COOR61 is a free carboxyl group may be used for the reaction in the form of a salt, e.g., an alkali metal salt or an alkaline earth metal salt. ~oreover, when Y is a protected amino group, a lower alkanoyl group, e.g., acetyl or propionyl group or an aralkyloxycarbonyl group, e.g., benzyloxycarbonyl group may be preferably used as the protecting group for said amino group. It is preferred to carry out the above-mentioned reaction at a temperature of 50 to 150 C.
When -COOR is the protected carboxyl group and/or Y is a protected amino group, the subsequent optional removal of said protecting group or groups may be conducted in a conventional manner, e.g., hydrolysis, solvolysis, t;;~1t7~

acid-treatment or reduction.
Since all of the above-mentioned reactions of the invention can be carried out without racemization, the compound in an optically active form can be readily obtained by the use of optical active isomer cf the compound (II) or (IV) as the starting compound.
The compound of formula (I) can be used for pharm-aceutical use either in the free form or in the form of a salt thereof. Suitable salts of the compound of formula (I) for pharmaceutical use include, for example, pharm-aceutically acceptable salts thereof for example alkali metal salts (e.g., sodium salt or potassium salt), al~aline earth me-tal salts (e.g., calcium salt or magnesium salt~, heavy metal salts (e.g., zinc salt), ammonium salt, organic amine salts (e.g., triethylamine salt, pyridine salt or ethanolamine salt), basic amino acid salts (e.g., lysine salt, arginine salt or histidine salt), and the like.
These salts can be obtained by treating compounds of formula (I) with the stoichiometrically equimolar amount of the corresponding organic or inorganic base.
The compound of formula (I) and a salt thereof may be administered either orally or parenterally and may also be used in the form of a pharmaceutical preparation containing the same compound in admixture with pharm-aceutical excipients suitable for oral or parenteraladministration. The pharmaceutical preparations may be in solid form e.g., tablets, capsules or suppositories or , - ~

~,~t~ 7 :~
,- g in liquid form e.g., solutions, suspensions or emulsions.
Moreover, when administered parenterally, the pharmaceutical preparation may be used in the form of injections.
As mentioned hereinbefore, the compounds of formula (I) of the present invention and salts thereof show potent platelet aggregation-inhibiting activity, and are useful for the treatment, amelioration and/or prophyla~is of a varie-ty of thrombosis or embolism e.g., cerebral thrombosis, coronary artery thrombosis, pulmonary thrombosis, pulmonary embolism, peripheral vascular embolism, thromboangiitis, and so forth. For example, when the collagen-induced platelet aggregation-inhibiting activity of a test compound is estimated in vitro, (~)-4-[2-(4-chlorophenyl)sulfonylamlno-l-methylethyl]phenoxyacetic acid of the present invention shows about 4 times as strong a platelet aggregation-inhibiting activity as that of 4-(2 benzenesulfonylaminoethyl) phenoxyacetic acid disclosed in Japanese Patent Publication (examined) No. 35910/1982. Moreover, the compounds of formula (I) and salts thereof are low in toxity and are safe for use as a medicine.
Concomitantly, the starting compound (II) of the present invention may be prepared, for example, by reacting a compound of the formula:

~1 ~2 ~3 14 R7 (VI) ~ ~,7~76~
, .

wherein R is a hydroxy group or a protected hydroxy group and Ring A, Rl, R2, R and R are the same as defined above, with a phenylsulfonyl halide derivative of the formula:

R SO2X (VII) wherein R5 is the same as defined above and x2 is a halogen atom, in the presence of an alkali metal carbonate or an organic amine in a solvent, and if required, removing 10 the protecting group from the product obtained above.
Alternatively, the starting compound (II) in which either one of R2 and R4 is a lower alkyl group and the othex is a hydrogen atom and Rl and R3 are hydrogen atoms may be prepared by reacting the compound of the formula:

R7 _ ~ COCH2NH2 (VIII) wherein Ring A and R7 are the same as defined above, with 20 the compound (VII) in the presence of an alkali metal carbonate in a solvent, reacting the product with a lower alkyl magnesium halide to give a compound of the formula:

,R ( or R ) R7 ~ ~OH
H2NHSO2R (IX) ,7~6~

wherein Ring A, R , R , R and R are the same as defined above, subjecting the compound (IX) to catalytic hydrogenation in the presence of palladium carbon, and if required, further removing the protecting group therefrom.
On the other hand, the starting compound (IV) may be prepared, for example, by reacting a compound of the formula:

IRl 2 yl ~ ~ OH (X) wherein yl is an amino group, a protected amino group or a reactive residue and Ring A, Rl, R , R3, and R are the same as defined above, with the compound (III) in the presence of an acid acceptor in a solvent, and if required, removing the protecting group or groups from the product in a conventional manner.
Experiment 1 Effect on collagen-induced platelet aggregation (in vitro Nine volumes of blood collected from a healthy human were mixed with one volume of 3.13 ~ (w/v) trisodium citrate solution, and the mixture was centrifuged to give platelet-rich plasma ("PRP") as the supernatant. rrhe bottom layer was further centrifuged to give platelet-poor plasma ("PPP") as the supernatent. PRP was diluted with PPP so that the platele-t count was about 4x105 cells /mm3. 25~1 of a test compound solution containing an equimolar amount of sodium hicarbonate was added to 200 ~ll of said diluted PRP. After ~, the mixture was stirred for 2 minutes at 37 C, a collagen solution [25-29~g/ml solution : Biochim. Biophys. Acta, 186, 254 (1969)] was added thereto to induce platelet aggregation.
The degree of platelet aggregation was examined by Born's 5 method (Nature, l94, 927 (1962)), and the platelet aggregation-inhibiting activity of the test compound was estimated. The platelet aggregation-inhibiting activity of the test compound was expressed as IC50, i.e., the concentration of the test compound required to induce 50~
inhibition of collagen-induced platelet aggregation. The results are shown in the following Table 1.

Table 1 Collaaen-induc~d r~latelet a~gregation~inhibiting activitv (in vitro) ¦Test ~rC5o(~g/ml) (the com?ounds of the presen. inven.ion) Compound No.l 0.7 Compouncl No.2 0.5 Com~ound No.3 0.5 no~n Com ound 2 ~) note : chemical name of each test corn?ounc' :

Co.npound i~o.l : (+)-4-(2~ chloro~henyl)sulfonylaninopro?yl) phenoYyacetic acic ~ ;~77~
~ 13 -Compound No. 2 ~ 4-[2-(4-chlorophenyl)sulfonylamino-l-methylethyl]phenoxyacetic acid Compound No. 3 : (~)-4-[2-(4-bromophenyl)sulfonylamino 1-methylethyl]phenoxyacetic acid Known : 4-(2-benzenesulfonylaminoethyl)-Compound phenoxyacetic acid (the compound disclosed in Japanese Patent Publication (examined) ~o. 35910/1982) Experiment 2 .
Effect_on arachidonic acid-induced pulmonary embolism (in vivo A test compound (suspended or dissolved in an aqueous sodium bicarbonate and 0 25% carboxymethylcellulose solution) was orally administered to ddy-male mice (5 weeks old, 10 mice per group) fasted overnight. Three hours later, arachidonic acid (125 mg/2.5ml of 1~ NaHCO3 solution + 7.5 ml of 0.9% aqueous sodium chloride /kg) was injected to the tail vein of mice to induce pulmonary embolism, and the recovery time(minutes) of locomotive activity of the mice (i.e., the duration from the injection of arachidonic acid to the time the mice recovered from respiratory distress and began to walk) was compared with that of a control group of mice to which an aqueous 0.25% CMC solution was administered instead of the test compound solution. The inhibiting effect of each test compound on arachidonic acid-induced pulmonary embolism was estimated in terms of a minimum effective dose, i.e., the dose required to shorten the recovery time by at least 15% as compared with the control group. The ~ 2~7~

results are shown in the following Table 2.

Table 2 Inhibiting effect on arachidonic acid-induced pulmonary embolism.

Test Compounds*) Minimum Effective Dose (mg/kg) (the compounds of the present invention) Compound No. l l.O
Compound No. 2 0.3 Compound No. 3 0.1 Compound No. 4 0.1 Compound No. 5 O. 03 Known Compound , 30 *) note : chemical name of each test compound :
ompound No. 4 : (+)-4-(2-benzenesulfonylamino-l-methylethyl)-2-fluorophenoxyacetic acid ompound No. 5 : (+)-4-[2-(4-chlorophenyl)sulfonylamino-l-methylethyl]-2-fluorophenoxyacetic acid Compound Nos. 1~3 and Known Compound are the same as entioned in Experiment l.

~'~77~;

Experiment 3 -Effect on bleeding time (in vivo) . _ _ A test compound (suspended or dissolved in an aqueous 0.25~ carboxymethylcellulose solution) was orally administered to ddy-male mice (5 weeks old, 10 mice per group) fasted overnight. Three hours later, the tip (ca.2 mm) of the tail was cut off under ether anesthesia, and said tail was immersed in physiological saline (37C) immediately. The bleeding time (seconds) of the medicated group of mice was compared with that of a control group of mice to which an aqueous 0.25% CMC solution was administered instead of the test compound solution. The prolonging effect of each test compound on the bleeding time was estimated in terms of a minimum effective dose, i.e., the dose required to induce at least 50 % prolongation of the bleeding time as compared with that of the control group.
[ Results ]
In the above-mentioned experiments, the minimum effective dose of Compound Nos. 1, 2 and 3 mentioned in Experiment 1 were 3 mg / kg, 10 mg / kg and 10 mg / kg, respectively, while the minimum effective dose of 4-(2-benzenesulfonylaminoethyl)phenoxyacetic acid disclosed in Japanese Patent Publication ( examined ) No. 35910/1982 was 30 mg/kg.

Example 1 7'7~7S
, (1) 4.74 g of 1-benzenesulfonylamino-2-(4-benzyloxy-phenyl)-2-propanol were dissolved in a mixture of 100 ml of tetrahydrofuran and 20 ml of water, and 4 29 g of oxalic acid were added thereto The mixture was subjected to ca-talytic hydrogenation in the presence of 10% palladium carbon under a hydrogen gas atmosphere (3.5 atoms) at 40-50C
overnight. After the reaction, the catalyst was filtered off. The filtrate was evaporated under reduced pressure.
Ethyl acetate was added to the residue, and the mixture was washed with an aqueous sodium bicarbonate solution and a saturated aqueous sodium chloride solution, successively.
The ethyl acetate solution was dried and evaporated under reduced pressure. The residue was recrystallized from a mixture of ethyl acetate and n-hexane, whereby 2.96 g of 4-(1-methyl-2-benzenesulfonylaminoethyl)phenol were obtained as colorless needles.
Yield 85~o m.p. 162.5-164C

(2) 2.96 g of the product obtained above were dissolved in 25 ml of acetone. 1~54 g of potassium carbonate and 1.87g of ethyl bromoacetate were added thereto, and the mixture was stirred at room temperature for 6.5 hours. 0.57 g of potassium carbonate and 0.68 g of ethyl bromoacetate were further added thereto and stirred overnight. After the reaction, acetone was evaporated under reduced pressure, and the residue was ex-tracted with ethyl acetate. The extract was ~ ~q~ 7~

washed with water and a saturated aqueous sodium chloride solution, and dried. The ethyl acetate extract was evaporated under reduced pressure, and -the residue was purified by column chromatography (solvent; toluene, and toluene: ethyl acetate=20:1 and 10:1?, whereby 2.04 g of ethyl 4-(1-methyl-2-benzenesulfonylaminoethyl)phenoxyacetate were obtained as colorless oil.
Yield 53~
Mass(m/e) : 377 (M ) IRvmaxat(cm ):3300,1750 NMR(CDC13,~): 1.19(3H,t,J=7Hz),1.30(3H,d,J=7Hz),2.6-3.3 (3H,m?, 4.28(2~,q,J=7Hz),4~59(2H,s),6.7 -7.9(9H,m) (3) 1.55 g of the product obtained above were dissolved in 16 ml of ethanol. 6.2 ml of a lN-aqueous sodium hydroxide solution were added thereto, and the mixture was stirred at room temperature for 2 hours. The mixture was evaporated under reduced pressure, and the residue was dissolved in 6 ml of water, and passed through a column packed wi-th a non-ionic adsorption resin (manufactured by Mitsubishi Chemical Industries Ltd. under the trade mark "HP-20", hereinafter referred to as "HP-20"). The column was washed with water and eluted with an aqueous 50 methanol solution. The fractions containing -the desired 7t7~7~;

product were collected and evaporated to remove the solvent.
Isopropyl alcohol was added to the residue, whereby 1.13 g of sodium 4-(1-methyl-2-benzenesulfonylaminoethyl)phenoxy-acetate were obtained as a colorless powder.
Yield 74%
M.p. 180C
Mass (m/e):394(M++Na),372(M++H) IR vNU~l*(cm~l):3280 NMR(D2o/~ (3H~d~J=7Hz)~2.6-3~l(3H~m)~4.43(2H~s)~6.7 -7.1(4H,m),7.4-7.8(5H,m) Free carboxylic acid:colorless caramel Mass(m/e):349(M+),179 IRCmHacxl3(cm 1):1740 NMR(CDCL3,~):1.19(3H,d,J=6.5Hz),2.86-3.29(3H,m), 4.63(2H,s), 6.67-7.83(9H,m) Example 2 (1) 11.13 g of dl-4-(2-aminopropyl)phenol hydrobromide were added to a mixture of 3.18 g of sodium carbonate, 100 ml of ethyl acetate and 100 ml of water. A solution of 9.71 g of benzenesulfonyl chloride in S0 ml of ethyl acetate and a solution of 3.18 g of sodium carbonate in 30 ml of water were added dropwise to said mixture at 0-5C under stirring.
After the mixture was stirred at 10C for 0.5 hour, the mixture was neutralized with 10 % hydrochloric acid. The X *Trade mark 7'~ 5 organic layer was separated therefrom, and the aqueous layer was extracted with chloroform. The above-obtained organic layer and the chloroform extract were mixed, and the mixture was evaporated under reduced pressure to remove the solvent.
The residue was recrystallized from n-hexane, whereby 7.48 g of dl-4-(2-benzenesulfonylaminopropyl)phenol were obtained as colorless prisms.
Yield 86~

m.p. 97-99C
Mass (m/e):291(M ) ~R vmUa~l(cm 1):3480,3440,3340,3300 NMR(CDC13+D2O~) 1.08(3H,d,J=6Hz),2.59(2H,d,J=6Hz)~

3.23-3.72(1H,m), 6.67(2H,d,J=9Hz), 6.84(2H,d,J=9Hz), 7.3-7.57(3H,m), 7.6-7.8(2H,m) (2) 7.4 g of the product obtained above and 3.51 g of potassium carbonate were added to 140 ml of acetone. A

solution of 4.66 g of ethyl bromoacetate in 10 ml of acetone was added thereto, and the solution was stirred at room temperature for 18 hours. After the reaction, the solution was condensed to a volume of about 50 ml under reduced pressure, neutralized with 10% ethanolic hydrochloric acid, and extracted with chloroform. The chloroform extract was evaporated under reduced pressure, and the residue was purified b~ silica gel column chromatography (solvent;

~ ~7~7~i75 , .

chloroform: methanol= 50:1 and 20:1), whereby 8.50 g of ethyl dl-4-(2-benzenesulfonylaminopropyl)phenoxyacetate were obtained as a colorless oil.
Yield 88.5 ~
Mass (m/e):377(M+) IR vnaext (cm 1):3270,1745 (3) 8.5 g of the product obtained above were added to 100 ml of a 10 % aqueous sodium hydroxide solution. The solution was stirred at 100C for 5 rninutes and at room temperature for 0.5 hour, and then adjusted to pH 3 with conc. hydro-chloric acid. The solution was extracted with chloroform.
The extract was dried and evaporated under reduced pressure, whereby 6.88 g of dl-4-(2-benzenesulfonylaminopropyl)-phenoxyacetic acid were obtained as a colorless powder.
Yield 87~
m.p. 131-132C (recrystallized from the mixture of acetone and n-hexane) Mass (m/e):349(M+) IR vrnnaUxiol(cm 1):3285,1730 NMR(CDC13-~D2O,~):1.06(3H,d,J=7Hz), 2.61(2H,d,J=7Hz), 3.20-3.75(1H,m), 4.55(2H,s), 6.77(2H,d,J=9Hz), 6.93(2H,d,J=9Hz), 7.22-7.60(3H,m), 7.63-7.82(2H,m) Sodium salt : colorless powder (recrystallized from ~c:7~
, ethanol) m.p. 192-194C
Mass (m/e):394(M++Na),372(M++H) IR vma~l(cm 1):3290,1615 NMR(DMSO-d6,~):0.85(3H,d,J=6.5Hz),2.24-2.70(2H,m), 3.04 -3.54(1H,m), 3.40(1H,s), 4.10(2H,s) 6.70(2H,d,J=9Hz), 6.88(2H,d,J=9Hz), 7.40 -7.90(5H,m) Example 3 ~ . _ (1) 5.043 of (R)-1-(4-methoxyphenyl)-2-aminopropane and 8.40 g of sodium bicarbonate were added to a mixture of 50 ml of methylene chloride and 50 ml of water. A solution of 4.86 g of benzenesulfonyl chloride in methylene chloride were added dropwise to the mixture at 5 to 10C and stirred at room temperature for 2 hours. After the reaction, the methylene chloride layer was separated therefrom, and the aqueous layer was extracted with methylene chloride. The methylene chloride solutions were combined, dried and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (solvent; chloroform, and chloroform : methanol = 50 : 1) and recrystallized from a mixture of isopropylether and methanol, whereby 6.76 g of (R)-1-(4-methoxyphenyl)-2-benzenesulfonylaminopropane were obtai.ned as colorless prisms.
Yield 88.6%

~,~t~6~75 m.p. 75-75.50C

[~1~ -18.84(C=1.072, methanol) (2) A solution of 14.3 g of boron tribromide in 20 ml of methylene chloride was added dropwise to 120 ml of methylene chloride containing 6.10 g of the product obtained above.
Said dropwise addition was carried out in an argon gas atmosphere at -78C. After the solution was allowed to stand at room temperature for 1.5 hours, 20 ml of water were added thereto under cooling. The methylene chloride layer was separated therefrom, washed with a saturated aqueous sodium chloride solution, dried and evaporated under reduced pressure. The residue was recrystallized from a mixture of chloroform and isopropylether, whereby 5.59 g of (R)-4-(2-benzenesulfonylaminopropyl)phenol were obtained as colorless plates.
Yield 96.1%
m.p. 92-92.50C

~]D0 -22.50(C=l.OO,methanol) (3) 5.24 g of the product obtained above, 3.31 g of ethyl bromoacetate and 2.49 g of potassium carbonate were added to 150 ml of acetone, and the solution was stirred at room temperature for l9 hours. 0.6 g of ethyl bromoacetate was further added thereto. After stirring for 8 hours, inorganic materials were filtered oEf, and the filtrate was ~L~t77~75 evaporated under reducecl ~reâsure. The residue was ~urifiec.
by siliea gel column chromatoaraphy ( solvent; chloro~orm :
.llethanol = 100 : 1 ), anc`i recrystallizecl from a mi,ture o.
chloroform and isopropylether, wher2by 5.05 a of ethyl (R)-4-(2-benzenesulfonylar~lino2ro~yl)2henoxyacetate were obtainec, as colorless needles.
Yield 7a 3~
m.p. 108.5~109C

~ci~D -11.03(C-1.015,methanol) IR vm j (em ~:3300,1750 ~;ass (m/e):377(M ) (4~ a.68 g of the product obtaine above were dissolved in a mixture of 1 g of sodiu.n hydroxicle, 80 ml of tetrahydrofuran and 10 ml of water. The mixture was stirred at room temperature for 1.' hours. ~fter the reaetion, tetrahydrofuran was evaporated under redueed pressure. The residue was made aeidie with lO~ hydroehloric acid and extraeted with ehloroform. The ehlorofor~ extract was washed with a satura~ed acTueous socium ehloriee solution, dried and evaporated under reduced pressure. The resic'ue was reerystallizecl from a mixture of isopropylether and methylene ehloricle, whereby ~.2 g of (R)-~-(2-benzenesulfonylaminopropyl)Dhenoxyaeetie aeid were obtained as eolorless needles.
Yielc' 97~

~ ~767S

m.?. 92-93C

~)D -12.01(C=1~074,mel,hanol) IR v ~ (cm ):3315,3215,17~-0,1705 The ~lass and ~ n~ data of this productwere identical with those of the product obtained in E~aMple 2-(3).
Sodium salt :colorless powder (recrvs.allized from ethanol) m.p. 193-196C

~)20 -15.41(C=1.012,methanol) Example 4 (li (S)-1-(4-methoxy?henyl)-2-aminopro?2n2 was treated in the saMe manner as described in Example 3-(1), whereby (S)-1-(4-methoxyphenyl)-2-benzenesulfon~lamino?-o~ane was obtained.
Yield 94.2Co ~ m,?. 7a.5-76CC

; (G)D +18.60(C=l.00, methano~) (2) The product obtained above was treated in the same manner as described in Ex2mple 3-(2), whereby (S)-~-(2-benzenesulfonylaminopropyl)~henol was obthLned.
Yield 90.2~
m.?. 92-94C

7675i , .. .

~)D0 +22.00(C=l.OO me hanol) (3) The proc.uct obta n_d above was treatec; in the s~me m~anner as described in Example 3-t3) where~y ethvl (S)-~-(2-benzenesul cnyl2mino?ro?yl)ph2nox~ace a.e was obt2in^c.
~rielc 75~
m.p. 109-110.5C

20 +10.50(C=l.00 methanol) (4) The ?roduct obtained above was treated in the same manner as cescribed in E~am?le 3-(4) wherehy (S)-4-(2-10 benzenesulfonylaminopropyl)phenoxyacetic acic was ob~ained.
Yield 99~
m.?O 89-91C

~G)D +11.90(c=1.008,methanol) IR ~nu~ol(cm ):3315 3215 1740 1705 15 The ~lass and ~iR data of this product were identical with those of the product obtcined in E~ample 2-(3).
Sodium salt :colorless powder (recr~stallized from ethanol) m.p. 192-195C

20 ~)D +15.13~(C=1.004 methanol) 77~i~7~

Exam?le 5 (1) A mixture of 2.32 g of ~+) -4-(2-a-inopro~yl)pher hydro~romide, 4.2 g of soaium bicarbonGte, 50 ml of water, 100 ml of ethyl acetate and 2.06 a of 4-methoxyphQnylsul'onyl chloriaewas stirred at room teinpercture for 3 hours. AEter the reaction, the ethyl acetate layer was separatec thereLrom, driec and evaporated to remove the solvent, wh-re~y 2.4 g of (+) -4-(2-(4-methoxyphenyl)5ulfon~rlaminopropyl)phenol were o~tained as a brown oil.
Yield 75~
.p. 119-120.5C~recrvs.allization from n-hexane) IR Vm X (cm ): 3420,3260 (2) A mi~ture OL 2.37 g of the product ob~ainec above, 1.21 ~ of methyl bromoacetate, 1 ~ of potassium carbonate and 30 ml of acetone was stirred at room temperature for 24 hours.
After the reaction, acetonewas distilled o'f. ~iate?-was added to the residue, and the mi~turewas ext~acted with ethyl acetate. The e.~tractwas evaporated to relmove ethyl acetate under reduced ~ressure. ~ethyl ~+)-4-~2-~4-methoxy~henyl)sulfonylGminopropyl)phe~oxyacetate obtained asthe crude productwas dissolved in 30 ml of me~hanol, and 15 ml of~0 ~ aqueous sodium hydro~;ice solution were added thereto. The mixturewas allowed to stand at room temperature for 1 hour. Then, the mixture wasmade acidic with 10% hydrochloric acid, and extracted with chloroform.

~ ~77~

The extract was dried and evaporated to eemove the solvent.
The residue was purified by silica gel column chromatography (solvent; chloroform, and chloroform : methanol = 19 : 1), whereby 2.01 g of (')-4-[2-(4-methoxyphenyl)sulfonylamino-propyl]phenoxyacetic acid were obtained as an oil.
Yield 77%
Mass(m/e): 379(M+) IR vmCHC13(cm 1):3680,1738 NMR (CDC13,~) :1.06 (3H,d,J=7.3Hz), 2.58(2H,d,J=6.6Hz), 3.83(3H,s), 3.2-3.6(1H,m), 4.60(2H,s), 6.6~7.0(6H,m), 7.61(2H,d,J=9Hz) (3) 1.7 g of the product obtained above was dissolved in 10 ml of methanol, and 5 ml of a lN-aqueous sodium hydroxide solution were added thereto. The solution was evaporated to remove the solvent. The residue was dissolved in 10 ml of water, purified by column chromatography, and recrystallized from a mixture of isopropyl alcohol and water, whereby 1.43 g of sodium (+)-4-[2-(4-methoxyphenyl~sulfonylaminopropyl]-phenoxyacetate were obtained as colorless granules.
m.p. 177-179C
Mass(m/e): 424(M++Na),402(M++H) NMR (D2O,~) :1.14(3H,t,J=6Hz),2.38(1H,d,d,J=14Hz,J=9Hz), 2.62(1H,d,d,J=14Hz,J=5.5Hz), 3.1-3.5(1H,m), ~L~7767~;

3.84(3H,s), 4.39(2~rs), 6.62(2H,d,J=9Hz), 6.85(2H,d,J=8Hz), 6.86(2H,d,J=9Hz), 7.44(2H,d,J=8Hz) Example 6 (l) A mixture of 2.69 g of (+)-1-(4-methoxyphenyl)-2-aminobutane, 6.3 g of sodlum bicarbonate, 60 ml of water, 120 ml of ethyl acetate and 2.65 g of benzenesulfonyl chloride was stirred at room temperature for 3 hours. After the reaction, the ethyl acetate layer was separated therefrom, dried and evaporated under reduced pressure. The oily residue thus obtained was dissolved in 50 ml of methylene chloride. A solution of 9.02 g of boron tribromide in 10 ml of methylene chloride were added dropwise thereto at a temperature of -50 to -60C. The mixture was stirred at room temperature for 2 hours. After the reaction, the mixture was cooled, excess boron tribromide was decomposed with water, and 50 ml of chloroform were added thereto. The organic layer was separated therefrom, dried and evaporated to remove the solvent. ~he residue was purified by silica gel column chromatography (solvent ; ethyl acetate : n-hexane = l : 9 to l : 3), whereby 3.70 g of (~)-4-(2-benzenesulfonyl-aminobutyl)phenol were obtained as a pale yellow oil.
Yield 81%
Mass (m/e):305(M ) ~.

~7~i7~

IR vc C13(cm 1):3600,3380,1608 max (2) The product obtained above was treated in the same manner as described in Example 5-(2) to give (+)-4-(2-benzenesulfonylaminobutyl)phenoxyacetic acid as an oil.
Yield 68~
IR VrcaHxcl3(cm 1):3380,1738 Examples__ to 20 (1) The corresponding starting compounds were treated in the same manner as described in Example 5-(1) or 6-(1) to give the compounds shown in Table 3 [In the following Tables, (+) and (-) express the optical activity of each compound obtained].

Table 3 Rl R2 Rl R2 NH2- - ~ R7 ~ R 5O2NH-~- r~ OH

(VI) (II) (part 1) (Ring A=p-phenylene group, Rl=H, R2=H, R7=oH in Example 7, 9 and 10, and R7=oCH3 in Example 8 and 11 to 19) 27~6~7~

. _ E~; . Co.~l~oun C7 ( I I ) ~S R5 F~3 ----!~- - I Y
7 C ] ~ C ~1 3 j ~ ~ 1 0 0 G I O i 8 F~ C.~3 IH I 99C Oi1 9 C 1 ~ n C 4 r~ 9 ~ 6 3 G I O i 1 1 O H ¦ 2 5 ¦ 1 1 5 1 1 6 C
11 ~ @~ H ¦ n-C3ll~¦ 75~O
12 /7~ H n C ~ H C~ 7 4 -O
~\~ I 12 ~ . 5-12a . 5 OC
1--3 1 ~ ~;CH176OG
1 4 /r~ H C~; 6 1 OG
~ (-) ~ 172-1 / . 5 OC
1 5 e ~ ~ ( ) ¦ 1 7 2 1 7 2 5 O C
( ) ¦ ¦ 1 0 3 1 0 8 . 5 C
¦ C1~ t + ) ¦ 108 108 S C18 1 ~ ~ )3 223.5 224.5OC
19 ¦ _~ H I CH3 223 . 5 225 OC
-(part 2) ( Ring A= ohenylene group, Rl=H, R =OCH3) _ ~:x . Coln~)ounc ( I I ) NO. R5 IR3 IR2 I Yie1d _ I ~d __ ` ~77~7~i .. .... , . ___ . , ~ H CH3 87%
__ _ 135-136C
~ 2) The corresponding starting compounds were treated in the same manner as described in Example 5-(2), whereby the compounds shown in Table 4 were obtained.

Table 4 Rl R2 Rl R2 R SO2NH-r-c- ~ -OH , R SO2NH-C-C- ~ -OCH2COOR

(II) ~I) (Part l)(Ring A= phenylene group, Rl=H, R2=H, R6=H) . _ Ex. Compound (I) Nos. _ Yield ~
R5 R3 R4 M.p. (recrystallization solvent) IR and/or optical rotation . .
7 Cl- ~ CH3 H 132-136C(chloroform-n-hexane) IR vmUaxOl(cm-l): 3340,3260,1780 _ ~
8 F ~ ~ CH3 H 134-137C~(ethyl acetate-n -hexane) IR vnujol(cm-l): 3290,1730 _ _ max 9. Cl- ~ n-C4Hg H 73%, oil IRv CHC13(cm~l): 1730 10. H C-2HS 71~, oil _ _ L________ _ ~ IR vneat(cm~l): 3280,1730 - 32 ~776~7~

lT ~ ~ C r~7 16~o~-, oil~
I r~ vl~e~`t (cr~ 3280,17.C
12 ~ ¦E{ In-CL~H9 ~ S~, oil ~ naC~t ( C !n 1 ) : 3280,1730 13 ~\~ H i-~,~17 G~ ~~ ~~~ ~~ --- - - ---- _ ~=~ J 137-133C(eth~l acetate-n -he-.ane) _ ~ l IP vrn~U~l(cr:l 1): 3300,17~-C
14¦ ~ ¦ H ¦CH3 15-o~ oil l ¦ ¦ ¦(G)D -11.26(C=1.039,methanol) lS¦ ~ ¦ H IC+H3 ¦ Sl-o~ oil G)D +11-10 (C=1.020,methanol) 16 I CH~ H 60~ j Cl ~ ~(~) 132-133CC(ethyl ac2tate-n -he~ane) I IP~ vrla3 (cm ): 3300, 3275, i 1725, 1700 17 l 1 ~ G ) D -17.33(C=1.027,methanol) Cl ~ '(+) 132.5-13'C(iso~ropylether-chloroform) I~ Vma~ (crn ): 3300, 3275, ~)D +17.97(C=1.007,met'lanol) 18 ~ CH3 1 Br ~ ! ~(~) chloroforr-l) l ~C)D -7.~4(C=0.790,me-.hcnol) 19_ . .. I .
~ , l(+) 150.5-152C(iso[~ro?~lalchohol-! I chloro~orn,) , .1 ~G)D +~.07(C=1.016,1~1ethanol) . . ._ ._ _ . .

~;~776 7~

(part 2)(Ring A= phenylene group, Rl=H, R6=H) Ex. Compound (I) No. R5 ~ and ~ H CH3 94~, oil _ IR vmUa~ol(cm-l): 1738 Sodium salt of the compound of Ex. No. 9 : m.p.

Example 21 (1) A mixture of 4.72 g of (+)-4-(2-benzyloxycarbonyl-amino-l-methyethyl)phenol, 2.53 g of methyl bromoacetate, 50 ml of acetone and 3.43 g of potassium carbonate was stirred at room temperature overnight. After the reaction, the mixture was evaporated to remove acetone, and water was added to the residue. The aqueous mixture was extracted with chloroform, and then the extract was dried and evaporated under reduced pressure, whereby 5.68 g of methyl (+)-4-(2-benzyloxycarbonylamino-1-methylethyl)phenoxyacetate were obtained as an oil.
Yield 96%
Mass (m/e):357(M ) IR vmaexat(cm 1):3200-3500,1755,1712 .~ 776t7~

(2) 5.36 g of the product were dissolved in 60 ml of methanol, and 2 ml of conc. hydrochloric acid were added thereto. The mixture was subjected to catalytic hydrogenation in the presence of 0.6 g of 10~ palladium carbon at room temperature under an atmosphere pressure.
After the reaction, the catalyst was filtered off, and the filtrate was evaporated under reduced pressure. The residue was recrystallized from a mixture of isopropylalcohol and ether, whereby 3.06 g of methyl (+)-4-(2-amino-1-methyl-ethyl)phenoxyacetate hydrochloride were obtained ascolorless crystals.
Yield 79%
m.p. 99-104C
Mass (m/e):223(M+) lS IR vmU~l(cm 1):2400-2800,1732 (3) A mixture of 1.82 g of the product obtained above, 50 ml of ethyl acetate, 1.76 g of sodium bicarbonate, 30 ml of water and 1.53 g of 2,4,6-trimethylphenylsulfonyl chloride was stirred at a temperature of 5 to 10C for 2.5 hours.
~fter the reaction, the ethyl acetate layer was separated therefrom, dried and evaporated under reduced pressure Methyl (~)-4-[2-(2,4,6-trimethylphenyl)sulfonyl-amino-1-methylethyl]phenoxyacetate obtained as the crude product was dissolved in 20 ml of methanol, and 8 ml of a lN-aqueous sodium hydroxide solution were added thereto. The mixture 7~t75 was allowed to stand for 1 hour. Then, the mixture was evaporated to remove methanol, neutralized with 5% hydrochloric acid, and extracted with chloroform. The chloroform extract was dried and evaporated to remove the solvent, whereby 1.6 g of (f)-4-[2-(2,4,6-trimethylphenyl)sulfonylamino-1-methylethyl]phenoxyacetic acid were obtained as a viscous oil.
Yield 59%
Mass (m/e): 391~M ) IR vmCaHcl3(cm 1):1735,1600 Hl-NMR (CDC13,~) :1.17 (3H,d,J=6.4Hz), 2.30(3H,s), 2.48(6H,s), 2.6-3.2(3H,m), 4.65(2H,s), 6.80(2H,d,J=9Hz), 6.91(2H,s), 6.98(2H,d,J=9Hz) Example_22 to 24 (1) The corresponding starting compounds were treated in the same manner as described in Example 21-(1) and (2) to give the compounds shown in Table 5.

Table 5 yl-C-C~ OH > ~ Y-C c~ ocH2COOR61 7~

~Ring A= phenylene group Rl=H, R2=H, R61=CH3, Yl=NHCOOCH2-~), Y=NH2 Ex. _ . Compound (IV) _ _ Nos. Yield R3 R4 M~po __ . . _ .
22 CH3 H 81~
123.5-125C(hydrochloride) __ . _ .
23 C2H5 H 60~
138-139C(hydrochloride) 24 ¦ H C2H5 59%
. 98-100C(oxalate) (2) The corresponding starting compounds were treated in the same manner as described in Example 21-(3) to give the compounds shown in Table 6.

Table 6 Y~ )-OCH2COOR 1 ~ R5502NH~ 3-oCH2cooR

(IV) (I) (Ring A=phenylene group, Rl=H, R2=H, R6=HI R61=H, Y=NH2 ) ¦EX . ¦ Compound (II) -INos. ¦ ~ ¦R4 IYield, M.p., IR

~t~ ~7 22 -CH3 _ _ Br- ~ 140.5-142C(ethyl acetate-n -hexane) _ _ IR Vmna~Ol(cm l) 3290,1730 23 fi-~ C2H5 H 86%
Cl- ~ 126-128C(ethyl acetate-n -hexane) IR vma~l(cm~l): 3270,3180,1780 . . _ _ 24 Cl- ~ H C2H5 100~, oil . _ IR vCaHCl3(cm~l):1735 Sodium salt of the compound of Ex. No. 22:
m.p.216-219~5C
Examples_25 to 33 The corresponding starting compounds were treated in the same manner as described in Example 21 to give the compounds shown in Table 7.

Table 7 Rl R2 'Rl R2 yl C-C- ~ -OH ? ~ ~ R5So2NH-c-c- ~ -OCH2COOR6 R3R4 (X) 1314 (I) (part l) (Ring A= phenylene group, Rl=H, R2=H, R6=H, Yl=NHCOOCH2 ~ ) Ex. Compound (I) Nos. _ _ _ Yield R5 R3 R4 M.p.(recrystallization solvent) _ IR and/or optical rotation ~ 76~i 25 ! ! 2~ ~ H I C H 3 1 o o PC ~ oil IR~ Vr - ~ 3 (Cm ) 1730 26 2~3- CH H 178-179 C(ethyl acetate-n --hexan~) ¦
_ _ IX vn;lU~l(cm 1): 32;30,1730 27 ~~ H C~3 100%, oil Cl IR vnna~t (cm ):3300,1730 28 - -- CH 3 - H 100 CC, O i 1 C1 IP VrnnaXt (Cm 1) 3300,1730 29 ~ H C H 3--- 1 0 0 Q ~ oil Cl TR vrleat (cm 1) 3320,1735_ H CH3 100%, oil j F~ IR VrC1H~,13(Cm 1~ 3500,3300,1735 C1 I ~
31 C F H C H 3 100 C, O i 1 3~ Vn a a ( C m 1) 3320,1730 . _ . . .
32 C1~ H CH3 100~, oil . Cl IR vr~aHxl (cm 1) :3500,3380,1735 ~. .
33 H CH3 100%
3~3~ 99-102 C(decomo ethyl acetate-n-hexane IR Vn~jO1(Cm 1) 3280,1730,1710 max __ (2art 2) (R =H, R =CH3, R3=H, R~=H, ~ =OCLI3) . .
EX ~ j COm~OI~nd ( I ) ~OS 5 ~ 6 Y1e1d R ~ -OCH2COOR ~I P (recrystallization solvent) _ IR and/or optical rotation ..

- 39 ~ 75i 34~ CCH;,COOH ~ 90%
49-51 C ( isopro~vlalcho'lol-~,;ater ) . . IR vr~ o-(cr~ 17~0 ~-OC~i2COO~ 90%
i C14~ l lGS.~-108.5C(ethyl ace.QI.e-i F n-hexane ) i I~ vnU]l(cm-l) 1740 ! , _ .
36 ~ -OCH2COOH 93~,oil CH3~ F IR vnu~ol(cm 1) 17ao _ . _ ._ ........ ~
37 ~ -OCH2COO~1 70Oo CF ~ F 10~-10~C(isopro~vlalchohol IR vr~ Jl(cm ):1720 __ . _ .. ._ . . _ .
38i ~ -C~2cH 6 2 %
C2~ l 133-1~ û ~C(etnyi acetate-F n-hexane) IR v U~l(cm l) l7ao _ _ ... _ . . __ ' 3 9 ~ ~3-ocH2cooH 9 6 ~o r 105-106 C ( iso2ropylalchoho1 F -water) IR vma] (cm ):1730 _ .__ .
ao ~9-ocH2coo~l 96%~oil C1~3- 1~~
_ ~ ~ IR vmax (cm ):1740 ~L~77~7~

. _ .
41 - ~ OcH2cooH 95%, oil 3 ~ ~
F IRVmaxt(cm 1)-1740 _ 42 ~ OCH2COOH 74~
3 ~ / 118-120C(ethyl acetate-~ n-hexane) _ _ IR vmu~ol(cm 1):1740 The properties of sodium salts:
Example.No.25: m.p.226-228.5C
Example.No.26: m.p.l27-131C(decomp.) Example.No.32: m.p.206-207C
Example No.33: m.p.226.5-229C

Example 43 A mixture of 1.56 g of methyl (~)-4-(2-aminopropyl)-phenoxyacetate hydrochloride, 48 ml of ethyl acetate, 2.07 of potassium carbonate, 16 ml o water and 1.6 g of 4-nitro-phenylsulfonyl chloride was stirred at room temperatureovernight. The ethyl acetate layer was separated therefrom, dried, and evaporated under reduced pressure to remove the solvent. The residue was recrystallized from a mixture of ethyl acetate and n-hexane, whereby 2.14 g of methyl (~)-4-[2-(4-nitrophenyl)sulfonylaminopropyl]-phenoxyacetate were obtained as pale yellow prisms.
Yield 87%

.

- 41 ~7767S

m.p.l27.5-128C
Mass(m/e): 408(M ) IR vma~ol(cm 1):3320,3280,1740 NM~ (CDC13,~) :1.21 (3H,d,J=6.4Hz), 2.5-2.7(2H,m),3.3 -3.7(1H,m),3.81(3H,s), 4.58(2H,s), 6.67(2H,d,J=8.3Hz), 6.91(2H,d,J=8.3Hz), 7.78(2H,d,J=8.7Hz), 8.22(2H,d,J=8.7Hz) Examples 44 to 51 The corresponding starting compounds were treated in the same manner as described in Example 43 to give the compounds shown in Table 8.

Table 8 Rl R2 Rl R2 Y- - ~-OCH2COOR I ~R 502NH-C- C-~OCH2COOR

(Ring A=phenylene group, Rl=H, R2=H, R6=CH3, R61=CH3 ~ Y=NH2 .
Ex. Com ound(I) Nos. _ _ Yield ~
. ---- - -- - R4 M p. (recrystallizatlon solvent) ~7~7~;

44 _ H CH3 94%
NO2 ~ 128.5-130.5C(isopropylether) IR vnU3l(cm~l): 3250,1745 CH3 H 77%
Br-~ 115-116C(methanol-~=~ isopropylether-n-hexane) . IR vnU~l(cm~1): 3260,1750 46 ~ H CH3 83~, oil Cl IR vneat (cm-l): 3320,1760 47 CH3 H 93~O~ oil C1 IR Vmnaexat(cm-l) 3310,1760 48 ~ CH3 H CH3 94%~ oil C1 IR vmaext (cm~l): 3340,1760 49 F ~ _ H CH3 86%, oil . C1 IR vma~1(cm~1)-3320,1755 50 CF3 ~ H CH3 90%~ oil Cl IR Vmaexat(cm-l): 3330,1760 _ 51 Cl ~ H CH3 85%, oil Cl m ~ IR vmU3ol(cm-l). 3315,1755 Example 52 :
(1) 23.1 g of (+)-4-(2-acetylamino-1-methyethyl)pheno].
were dissolved in 400 ml of acetone, and 19.9 g of methyl bromoacetate and 18 g of potassium carbonate were added thereto and the mixture was stirred overnight. 7.96 g of methyl bromoacetate and 7.2 g of potassium carbonate were further added thereto, and the mixture was stirred for 3 days.

7'767~i Af-ter the reaction, the mixture was evaporated under reduced pressure, and water was added to the residue. Then, the residue was extracted with ethyl acetate, washed with a saturated aqueous sodium chloride solution, dried and condensed to dryness, whereby 31.6 g of methyl (_)-4-(2-acetylamino-l-methylethyl)phenoxyacetate were obtained as a yellow oil.
Mass (m/e):265(M ) IR ~max (cm ):3310,1760,1650 (2) The product obtained above was dissolved in 200 ml of 6N-hydrochloric acid, and the solution was refluxed for 7.5 hours. After the reaction, the solvent was distilled off, and the residue was crystallized with tetrahydrofuran, whereby 19 g of (+)-4-(2-amino-1-methylethyl)phenoxyacetic acid hydrochloride were obtained as colorless solids.
m.p. 220.5-223C (decomp.) Mass (m/e):209(M ), 179 IR ~max (cm ):1730 (3) A mixture of 2.95 g of the product obtained above, 3.65 g of potassium carbonate, 30 ml of water and 2.45 g of 4-fluorophenylsulfonyl chloride was stirred at 80 C for 2 hours. After cooling, the mixture was adjusted to pH 1 with 6N-hydrochloric acid, and extracted with ethyl acetate.
The extract was condensed to dryness, and (_)-4-[2-(4-~` _ 44 ~ 76 fluorophenyl)sulfonylamino-l-methylethyl)phenoxyacetic acid obtained as the residue was treated with a lN-aqueous sodium hydroxide solution to convert it to the sodium salt. Then, said sodium salt was purified by chromatography on a column packed with HP-20, whereby 2.82 g of sodium (+)-4-[2-~4-fluorophenyl)sulfonylamino-l-methylethyl)phenoxyacetate were obtained as a powder.
Yield 60~
m.p. 213-214.5 C (colorless prism, recrystallized from a mixture of water and isopropyl alcohol) (4) 1.95 g of -the product obtained above are dissolved in 30 ml of water, and adjusted to pH 1 with 10~ hydrochloric acid. The mixture was extracted with chloroform. The chloroform extract was dried and evaporated to remove the solvent. The residue thus obtained was recrystallized from a mixture of ethyl acetate and n-hexane, whereby 1.65 g of (+)-4-[2-(4-fluorophenyl)sulfonylamino-1-methylethyl)phenoxyacetic acid were obtained as colorless prisms.
Yield 90~
m.p. 111.5-114C
H -NMR (CDC13,~) :1.19 (3H,d,J=6.2Hz), 2.6-3.3(3H,m), 4.63(2~,s),6.6-7.3(7H,m),7.6-7.9(2H,m) IR vmax (Cm-1):3300,1740 Mass (m/e): 367(M ) E~;~m~les 53 to 55 The corresponding s~arting compounc's were tr-atec'~ in t.he same manner as c;escribec in E~ aIî?1e 52 to aive the com?ouncs shown in TaDle 9.

Table 9 R'RZ R~RZ
Y ~ I c {9 o ll > ?~ 1~ s S o Z N 11 - C - C {9- o C 11 Z C o o R ' R3R4 ( X ) R3R~ (I) ( Ring ~.="henylene group, R =H, R =H, P~ =~, Y =``~HCOCH3) .
Ex. Com~ound(l ) ~OS- R5 R ¦R 1 ?-( recrystallization solvent) . ~_ .. _ --53F ~~~ H CH3 133.5-136C(decomp. ethyl 15 C13~ ~ acet2te-n-hexane _ _ I~ vnU~l(cm 1):327o~l7ao 54 H CH3 118-119.5C(decomp. ethyl Cl ~ ace.ate-n-hexane IR vmaxl(cm 1):3263,17dO
. .. --H CH3 131-133C(ethvl acetate-Br ~ n-hexane) _ ~ IR vma] l(cm ):32~0,1750 . ___.__ _ _ _ _ ~776~75 Exal~le 55 ~ mixture of 2.95 g of (+)-~-(2-a..lino-1-( methylethyl)phenoxyacotic acid hydrochloride, 3.~2 a OL
sodium ca~~oncte, 30 ml of water and 3.1 g of 2,5-dichloro~henylsulfollyl chloride was stirred a, ~0 CC for 3 hours. The reaction mixture was treated in the same manner as described in Example 43, whoreby (+)-4-(2-(2,5-dichloro~henyl)sulfonylamino-l-methylethyl)pheno~yacotic acid was obtained.
10~ .111.5-116.5C (decomp.)( recrystallizec from a mixture of ethyl acetate and n-hexane ) IR vnaxl(cm-1):3320,1740,1710 Hl-~J.-'~ (CDC13,~) :1.20 (3H,d,J=6.4Hz), 2.7-3.3(3H,m), 4.65(2H,s), 4.95(1H,m), 156.~2(2H,d,J=9Hz), 7.04(2H,d,J=9~z), 7.3-7.5(2~:,m), 7.S~~.l(lrl,l~.) Exam?le 57 .
(1) 1.98 g of 4-(2-amino-2-methylpropyl)phenol oxalate weresuspend2d in 40 ml of methylene chloride, and 6.27 g of triethylamine and 6.5 g of 4-chlorophenylsulfonyl chloride were added thereto. The suspension was refluxed for S hours. After the reaction, the solvent wasdistilled off.

The residue was dissolved in 50 ml of methanol, 35 ml of a 10 aqueous sodium hydroxide solution wereadded thereto, and the _ 47 ~ 77~

solution was refluxed for 40 minutes. The reaction solution was evaporated to remove the solvent, made acidic with 10 hydrochloric acid and extracted with ethyl acetate. The extract was washed with water, a dilute aqueous sodium bicarbonate solution, and a saturated aqueous sodium chloride solution, successively. Then,the extract was dried and evaporated. The residue thus obtained was purified by silica gel column chromatography (solvent; chloroform, and chloroform : methanol = 50 : 1?, and recrystallized from a mixture of ethyl acetate and n-hexane, whereby 1.40 g of 4-[2-(4-chlorophenyl)sulfonylamino-2-methylpropyl]phenol were obtained as pale yellow prisms.
Yield 53~
m.p. 131.5-133.5C
Mass (m/e):339(M+) IR vma~l(cm 1):3450,3310 (2) 1.50 g of the product obtained above were dissolved in 20 ml of acetone, and 0.91 g of potassium carbonate was added thereto. A solution of 0.84 g of methyl bromoacetate in 20 ml of acetone was added thereto under stirring at room temperature, and the mixture was stirred for 24 hours. The reaction mixture was evaporated to remove the solvent, and the residue was dissolved in a mixture of ethyl acetate and water.
The ethyl acetate solution was washed with water and a ~,.~..

- 48 ~ 7~7~

saturated aqueous sodium chloride solution, dried, and then evaporated to remove the solvent. Then, the residue obtained was recrystallized from a mixture of ethyl acetate and n-hexane, whereby 1.70 g of methyl 4-[2-(4-chlorophenyl)-sulfonylamino-2-methylpropyl]phenoxyacetate were obtained as pale yellow prisms.
Yield 94%
m.p.133-135C
Mass(m/e): 411tM+) IR vmUa~l~cm 1):3270,1750,1230 Hl-NMR (CDC13,~ 16 (6H,s), 2.78(2H,s), 3.81(3H,s), 4.52(1H,s), 4.63(2H,s), 6.85~2H,d,J=8.8Hz), 7.15(2H,d,J=8.8Hz), lS 7.41(2H,d,J=9Hz),7.75(2H,d,J=9Hz) (3) The product obtained above was treated in the same manner as described in Example 21 to give 4-[2-(4-chloro-phenyl)sulfonylamino-2-methylpropyl]phenoxyacetic acid.
m.p.l77-178C (recrystallized from a mixture of ethyl acetate and n-hexane) Mass(m/e): 397(M+) IR ~mnaU}l(cm 1):3300,1730,1710 Hl-NMR (CDC13+DMSO-d6,~) :1.13 (6H,s), 2.79(2H,s), 4.58(2H,s), 5.67(1H,s), 6.81(2H,d,J=8.8Hz), - a~ 9 ~ 6~5 7.16(2H,d,J=8Hz), 7.3-7.8(4H,m) Examples 58 to 60 The corresponding starting compounds were treated in the same manner as described in Example 52-(1) and (2). The resulting free carboxylic acids were reacted with methanol to give the corresponding methyl esters thereof, which were then treated in the same manner as described in Example 21-(3).
The compounds shown in Table 10 were thereby obtained.

Table 10 RlR2 RlR2 I3R4 RSSOzNH-C- - ~ O~H~COOR6 (part l)(Ring A=phenylene group, Rl=H, R2=H, R6=H, Yl=NHCOCH3 ) Ex. Compound(I) Nos. ~ ~ M.p.(recrystallization solven-Fr l optical rotation ;~

767~;

58Cl- ~ CH3 137-138C(ethyl acetate-n -hexane) IR vnU~l(cm~l) 3280J1740 [~]2D0 -8.63(C=1.019~methanol) _ ___ _ ~
59 ~-~ H CH3 95~
Cl ~ (+) 138-139C(ethyl acetate-n -hexane) IR vnmujxl(cm-l): 3280,1740 _ - - I]2DO +g.g2(C=1.008,methanol~

(part 2) (Rl=H, R2=CH3, R3=H, R4=H, R7=oH, Y=NHCOCH3) Ex. Compound(I) _ ¦
No. -R5 ~ ~OCH2COOR6 IR

60 Cl- ~ ~ OCH2COOH 92~,oil _ _ IR vmeaaxt (cm~l): 1740 Example 61 (1) 6.76 g of (+)-1-(4-benæyloxy-3-methoxyphenyl)-2-aminopropane were dissolved in 120 ml oE ethyl acetate, and a solution of 6.9 g of potassium carbonate in 60 ml of water was added thereto. A solution of 4.42 g of benzenesulfonyl chloride in 60 ml of ethyl acetate was added dropwise thereto, and the mixture was stirred for 45 minutes. The ethyl acetate layer was separated, dried and evaporated to remove the solvent, whereby 7.24 g of (~ (4-benzyloxy-3-methoxyphenyl)-2-benzenesulfonylaminopropane were obtained as a pale yellow oil.

... .. . .

- 51 - ~Z7~67~

(2) 7.16 g of the product obtained above were dissolved in 200 ml of tetrahydrofuran, and subjected to catalytic hydrogenation in the presence of 3 g of wet-10% palladium-carbon at room temperature under atmospheric pressure.

5 After the reaction, the catalyst was filtered off, and the filtrate was evaporated to remove the solvent. The residual yellow oil was dissolved in 60 ml of acetone, and 3.61 g of potassium carbonate and a solution of 2.66 g of methyl bromoacetate in 60 ml of acetone were added thereto. The 10 mixture was stirred overnight. After the reaction, acetone was distilled off, and water was added to the residue. The mixture was extracted with ethyl acetate. The ethyl acetate extract was washed with a saturated aqueous sodium chloride solution, dried and, evaporated to remove the solvent. The 15 residual pale yellow oil was dissolved in 35 ml of methanol, 35 ml of a lN-aqueous sodium hydroxide solution were added thereto, and the mixture was stirred for 1 hour. After the reaction, methanol was evaporated under reduced pressure.
The residue was made acidic with hydrochloric acid and 20 extracted with chloroform. The extract was dried and evaporated under reduced pressure to remove the solvent.
Then, the residue was purified by silica gel column chromatography (solvent; chloroform : methanol = 1000:1, 100:1, 10:1), whereby 4.06 g of (+)-2-methoxy-~-(2-25 benzenesulfonylaminopropyl)phenoxyacetic acid were obtainedas an oil.

- 52 - ~7767 Yield 62~
Mass(m/e): 379~M ) IR v C 3(cm 1):1730 max Example 62 (1) (+)-1-(4-methoxy-3-methylphenyl)-2-aminopropane and benzenesulfonyl chlorid~ were treated in the same manner as described in Example 61~ to give (+)-1-(4-methoxy~3-methylphenyl)-2-benzenesulfonylaminopropane.
(2) 11.48 g of the product obtained above were dissolved in 300 ml of methylene chloride and cooled at -60C. 29.7 g of boron tribromide were added dropwise thereto under stirring, and the mixture was stirred at room temperature for 1 hour. The reaction mixture was cooled, decomposed with water and extracted with chloroform. ~fter drying, the extract was evaporated to remove the solvent. The residual brown oil was dissolved in 320 ml of acetone, and 10.7 g of potassium carbonate and 7.89 g of methyl hromoacetate were added thereto. The mixture was stirred overnight. After the reaction, acetone was distilled off, and water was added to the residue. The mixture was extracted with ethyl acetate.
The ethyl acetate extract was washed with a saturated aqueous sodium chloride solution, dried and evapora~ed to remove the solvent. The residue was dissolved in methanol, a lN-aqueous sodium hydroxide solution was added thereto, and the mixture was stirred for 1 hour. After the reaction, methanol was ,i . ,, ,, , - 53 ~ 776~5 distilled off, and the residue was purified by silica gel column chromatography (solvent; chloroform : methanol =
1000:1, 100:1, lOol), whereby 13. 5 g of (~)-2-methyl-4-(2-benzenesulfonylaminopropyl)phenoxyacetic acid were obtained as an oil.
Yield 72 Mass(m/e): 363(M~

IR VmcaHxcl3(cm 1):1730 Examples 6 3 to 67 The corresponding starting compounds were treated in the same manner as described in Example 62 to give the compounds shown in Table 11.
Table 11 RlR2 RlR2 MH2 C C ~ -R7 --~ ~ RSSO2NH C C ~ OCH2COOR6 tR1=CH3, R2=H, R3=H, ~4=H, R7=OCH3) _ 54 1~7767~
_ . _ . . . , Ex. Compound(I) Nos. . _ ___ .
R5 ~ OCH2COOR6 M.p.(recrystallization solvent) _ C ~ 60%,oil 63 ~ ~ OCH3COOH
~=~ ~CH3 IR vCmaXC13(cm 1):1730 _ . . . . ~. .___ 64 ~ ~ OCH2COOH 62%
F 148-150C(ethyl acetate -isopropylether-n-hexane) IR Vmna~ol(cm-l) 1740 _ _ _ ~ OCH2COOH 72~
Cl- ~ F 130.5-132.5C(chloroform) IR Vmnau~ol(cm-l) 1720 ... _ 66 CH3 ~ - & OCH2COOH 138-1410C(ethyl acetate F -isopropylether IR vnu~ol(cm-l) 1740 _ _ _ 67 CF3 ~ ~ -OCH2COOH 163-164C(ethyl acetate -isopropylether ~ . IR Vmna~ol(cm-l) 1720 [Preparation of the starting compounds]

Preparation 1 _ __ (1) 78 g of 1-(4-benzyloxyphenyl)-2-chloroethanone and 63 g of hexamine were dissolved in 2.2 liters of chloroform, and the mixture was stirred at room temperature overnight.
rrhe mixture was condensed to a volume of 1.1 liters, and refluxed for 3 hours. After cooling, the precipitated K

77~7~j crystals were collected by Eiltration, washed and then dried.
The colorless crystals thus obtained were added to a mixture of 750 ml of ethanol and 120 ml of conc. hydrochloric acid, and the mixture was refluxed for 50 minutes. After cooling, S the precipitated crystals were collected by filtration, washed and then dried. 55.6 g of 2-amino-1-(4-benzyloxy-phenol)ethanone were obtained as colorless crystals.
Yield 67 %
M.p. 225C(decomp.) (2) 1.11 g of the product obtained above were dissolved in a mixture of 10 ml of tetrahydrofuran and 5 ml of water.
A solution of ].11 g of potassium carbonate in 10 ml of water and a solution of 1.41 g of benzenesulfonyl chloride in 10 ml of tetrahydrofuran were added dropwise thereto. The mixture was stirred at room temperature for 1.5 hours, and extracted with ethyl acetate. The ethyl acetate extract was washed, dried and evaporated to remove the solvent. The residue was recrystallized from ethyl acetate, whereby 1.34 g of 2-benzenesulfonylamino-l-(4-benzyloxyphenyl)ethanone were obtained as colorless needles.
Yield 89%
m.p. 148-149C
(3) 4.37 g of magnesium were suspended in 180 ml oE dried ether, and 4 drops of 1,2-dibromoethane were added thereto.

After the mixture was stirred at room temperature for 30 minutes, a solution of 18.3 g of methyl iodide in 50 ml of 56 - ~ 77 6t7~

ether was added dropwise thereto. A solution of 7.6 g of 2-( benzenesulfonylamino-1-(4-benzyloxyphenyl)ethanone in 150 ml of tetrahydrofuran was added dropwise to said mixture under stirring and cooling. The mixture was stirred at room temperature overnigh~, and then refluxed for 2 hours. After cooling, a dilute aqueous ammonium chloride solution was added to the mixture, and the mixture was extracted with ethyl acetate. The extract was washed, dried and then evaporated under reduced pressure. The residue was purified by silica gel column chromatography (solvent; chloroform, and chloroform : methanol = 50 : 1) and recrystallized from a mixture of ethyl acetate and n-hexane, whereby 4.92 g of 1-benzenesulfonylamino-2-(4-benzyloxyphenyl)-2-propanol were obtained as colorless crystals.
Yield 62%
m.p. 150-151C
Preparation 2 A tetrahydrofuran solution of 6.78 g of 1-(4-benzyloxy-3-methoxyphenyl)-2-nitropropene was added dropwise to a suspension of 2.15 g of lithium aluminum hydride in tetrahydrofuran. The mixture was stirred at room temperature and then refluxed. After the reaction, excess lithium aluminum hydride was decomposed with ice water, and the in-organic materials were filtered off. The filtrate was washed, dried and then condensed to dryness.

,.~ ,, 6 g of 1-(4-benzyloxy-3-methoxyphenyl)-2-aminopropane were obtained as a pale yellow viscous oil.
Yield 97%

Preparation 3 -(1) A dimethoxyethane solution of 5.25 g of potassium tert~butoxide was added dropwise to a dimethoxyethane solution containing 3.93 g of 2-fluoro-4-methoxyacetophenone and 4.57 g of p-toluenesulphonylmethylisocyanide. Said dropwise addition was carried out at a temperature below 10C. After the reaction, the mixture was added to ice water, and extracted with ether. The extract was washed, dried and condensed to dryness. The residue was purified by silica gel column chromatographyr whereby 3.83 g of 2-(2-fluoro-4-methoxyphenyl)-2-methylethanenitrile were obtained as a colorless oil.
Yield 83%

IRvmaX (cm ):2250 ~ 2) 15 ml of Raney Nickel were added to an ethanol solution of 5.05 g of the product obtained above, and 30 g of hydra~ine monohydrate were added dropwise thereto at a temperature between 40 and 50C. After the reaction, the catalyst was filtered off, and the filtrate was evaporated.
The residue was added to 15% methanolic hydrochloric acid, and the mixture was evaporated to remove the solvent. The - 58 ~ 67~
residue was recrystallized from a mixture of methanol and isopropylether, whereby 4.23 g of 1- amino-2-(2-fluoro-4-methoxyphenyl)propane hydrochloride were obtained as colorless crystals.
Yield 75%
m.p. 147-149C
Preparation 4 The corresponding starting compounds were treated in the same manner as described in Preparation 3 to give 1- amino-2-(3-fluoro-4-methoxyphenyl)propane.
Yield 99%

IRvmax (cm ):3270 Preparation 5 (1) 504 mg of 60% sodium hydride were added to tetrahydrofuran, and a solution of 2.47 g of triethylphosphonoacetate was added there-to under an argon atmosphere. The mixture was stirred at room temperature.
Then, a solution of 1.85 g of 3-chloro-4-methoxyacetophenone in tetrahydrofuran was added -thereto, and the mixture was stirred at room temperature. After the reaction, water was added to the mixture, and the organic layer was separated therefrom. The aqueous layer was extracted with ethyl acetate. The organic solutions were combined and evaporated to remove the solvent. The residue was purified by silica -_59~ 77~7S

gel column chromatography, whereby 1.47 g of ethyl 3-(3-chloro-4-methoxyphenyl)isocrotonate and 0.18 g of ethyl 3-(3-chloro-4-methoxyphenyl)crotonate are obtained.
ethyl 3-(3-chloro-4-methoxyphenyl)isocrotonate:
Yield 5.7 %
m.p. 67-68C
IR vnU~l(cm~l):1700 ethyl 3-(3-chloro-4-methoxyphenyl)crotonate:
Yield 7.1 oil IR vmnaeX (cm ):1710 (2~ 0.3 g of 10~ palladium carbon was added to an acetic acid solution containing 1.41 g of ethyl 3-(3-chloro-4-methoxyphenyl)isocrotonate, and the mixture was subjected to catalytic hydrogenation at room temperature under atmospheric pressure. After the reaction, the catalyst was filtered off, and the filtrate was condensed. Methanol and an aqueous sodium hydroxide solution were added to the residue, and the mixture was stirred. Then, the solvent was distilled off, and the residue was made acidic with hydrochloric acid. The aqueous mixture was extracted with ethyl acetate. The extract was washed with water, dried and then condensed to dryness. The residue was purified by silica gel column ;3 ~,~' .

- 60 - ~'~7767~

chromatography, and recrystallized from n-hexane, whereby 807 mg of 3 (3-chloro-4-methoxyphenyl)butyric acid were obtained as a colorless oil.
Yield 64~
m.p. 73.5-75C
(3) A solution of 12.23 g of the product obtained above, 6.49 g of triethylamine and 17.66 g of diphenylphosphorylazide in toluene was stirred at room temperature and then refluxed. 11.58 g of benzylalcohol were added thereto, and the mixture was again refluxed. Ethyl acetate was added to the reaction mixture, and said mixture was washed, dried and then condensed to dryness. 17.85 g of l-benzyloxycarbonylamino-2-(3-chloro-4-methoxyphenyl)propane were obtained as an oil.
Yield 100~
(4) 33 ml of an aqueous 25~ hydrobromide-acetic acid solution were added dropwise to an acetic acid solution containing 16.42 g of the product obtained above. After stirring the mixture, ether was added thereto, and the precipitated crystals were collected by filtration. 10.33 g of l-amino-2-(3-chloro-4-methoxyphenyl)propane hydrobromide were obtained.
Yield 78%
m.p. 163.5-165C

- 61 - ~.~ 7 Preparation 6 A mixture of 4.64 g of (+)-4-(2-amino-1-methylethyl)-phenol hydrobromide, 100 ml of ethyl acetate, 6.92 g of potassium carbonate, 40 ml of waer and 3.75 g of benzyloxycarbonyl chloride was stirred at room temperature overnight. After the reaction, the ethyl acetate layer was separated therefrom, washed, dried, and then evaporated under reduced pressure to remove the solvent. 4.82 g of (+)-4-(2-benzyloxycarbonylamino-1-methylethyl)phenol were obtained as a pale yellow oil.
Yield 85 ~
Mass (m/e):285(M ) IR vmnaexat (cm 1):3350,1690 Preparations 7 to 9 The corresponding starting compounds were treated in the same manner described in Preparation 6 to give the compounds shown in Table 12.

Table 12 RlR2 yl I C; ~ -OH ~X) R R

- 62 - ~q7767~ -(R1=H, R2=H, Ring A-phenylene, Y1=NHCOOCH2 ~
~ . .
Prep. ~ _ Compoun( Nos. R3 R4 Yield . . . . ~ . . ~

7 CH3 H olil ~ . __ ~ , __ ... . .. __ ~ . , 8 C2H5 H 85~

.___ _ _ .

9 - C2H5 oil Preparation 10 -(1) 4.19 g of 1-amino-2-(2-fluoro-4-methoxyphenyl)-propane hydrochloride were neutralized with a mixture of chloroform and an aqueous sodium bicarbonate solution. The chloroform layer was separated therefrom and condensed to dryness. Hydrobromic acid was added to the residue, and the mixture was refluxed. Then, the reaction mixture was evaporated, and the residue was recrystallized from a mixture of isopropylalcohol and isopropylether. 4.53 g of 3-fluoro-4-(2-amino-1-methylethyl)phenol hydrobromide were obtained.
Yield 95~
m.p. 182-183.5C
(2) 2.9 g of benzyloxycarbonyl chloride were added to a solution of 4.47 g of the product obtained above in ethyl acetate-water containing sodium bicarbonate and the mixture was stirred at room temperature for 1 hour. After the reaction, the ethyl acetate layer was separated therefrom, - 63 - ~ 7~75 washed and dried. Then, the ethyl acetate layer was condensed to dryness, whereby 5.82 g of 3-fluoro-4-(2-benzyloxycarbonylamino-1-methylethyl)phenol were obtained as an oil.
Yield 100%

~R vneat (cm~l) 3330 1690 max Preparation 11 l-amino-2-(3-fluoro-4-methoxyphenyl)propane hydrochloride was treated in the same manner as described in Preparation 10 to give 2-fluoro-4-(2-benzyloxycarbonylamino-l-methylethyl)phenol as a colorless oil.
Yield 100%

IR vmeaxt (cm 1):3350,1670 Preparation Example 12 (1) A mixture of 19.8 g of (+)-1-amino~2-(4-methoxy-phenyl) propane, 200 ml of ethyl acetate, 200 ml of water and 84 g of sodium bicarbonate was cooled at 5 to 10C under stirring, and 18.8 g of acetyl chloride in 100 ml of ethyl acetate were added dropwise thereto at the same temperature.
After the reaction, the ethyl acetate layer was separated therefrom, washed, dried and then condensed to dryness under reduced pressure, whereby 24.8 g of (+)-1-acetylamino-2-(4-methoxyphenyl)propane were obtained as an oil.

- 64 - ~ Z~ S

Mass (m/e):207(M+) IR vmnaexat (cm 1):3290,1650 (2) The pcoduct obtained above was dissolved in 750 ml of methylene chloride. After cooling to -60C, a methylene chloride solution of 69 g of boron tribromide was added dropwise thereto at the same temperature for 1.5 hours under stirring. After the mixture was stirred at room temperature, said mixture was again cooled to -50 to -60C. Water and methylene chloride were added to the mixture. Then, the organic layer was separated therefrom, and washed with an aqueous sodium bicarbonate solution and a saturated aqueous sodium chloride solution. The aqueous layers were combined, neutralized with an aqueous sodium bicarbonate solution, and evaporated under reduced pressure. The resulting oily residue was extracted with ethyl acetate. The extract was dried, and evaporated under reduced pressure, whereby 23.1 g of (+)-4-(2-acetylamino-1-methylethyl)phenol were obtained as an oil.
Yield 100~
Mass (m/e):193(M ) IR vmnaeat (cm 1):3290,3020,1655 Preparations 13 t_ 15 The corresponding starting compounds were treated in the same manner as described in Preparation 12 to give the compounds shown in Table 13.

- 65 - ~77~7~

Table 13 RlR2 yl I_C-~OH

(X) (Rl=H, R3=H, R4=H, Yl=NHCOCH3 Prep. Compound (X) , : Nos. _ . Yield R2~ -OH M.p.
. ._ ___ 13 (CH~3 ~ OH 94~
IR vnexat (cm~l): 3290, 1650 [a]20 -44.60 (C=1.009,methanol) . ,_~ . . -- . . ~ ~_ _ 14 CH3 ~ OH used for subsequent reactions (~) without isolation from the reaction solution . . ~ . . ",",~ . . . __ __ 15 CH3 ~ \~ OH 80%,oil ~=<Cl IR vmaexat (cm~l):3300,3100,1650 . __ . ~ . -- -- . ._

Claims (15)

1. A phenoxyacetic acid derivative of the formula:

wherein Ring A is a phenylene group or a phenylene group having 1 or 2 substituents selected from a lower alkyl group, a lower alkoxy group and a halogen atom; either one or two groups of R1, R2, R3 and R4 is/are a lower alkyl group, and the other groups are hydrogen atoms; R5 is a phenyl group or a phenyl group having 1 to 3 substi-tuents selected from a lower alkyl group, a halogen atom, a lower alkoxy group, a trihalogenomethyl group and a nitro group; and -COOR6 is carboxyl group or a protected carboxyl group, or a pharmaceutically acceptable salt thereof.
2. The compound claimed in Claim 1, in which Ring A
is a phenylene group or a phenylene group having 1 or 2 substituents selected from an alkyl group of one to three carbon atoms, a halogen atom and an alkoxy group of one to three carbon atoms; either one or two groups of R1 to R4 is/are an alkyl group of one to four carbon atoms, and the other groups of R1 to R4 are hydrogen atoms;
R5 is a phenyl group or a phenyl group having 1 to 3 substituents selected from an alkyl group of one to three carbon atoms, a halogen atom, an alkoxy group of one to three carbon atoms, a trihalogenomethyl group and a nitro group; and -COOR6 is a free carboxyl group or a carboxyl group protected with an alkyl group of one to three carbon atoms, or a pharmaceutically acceptable salt thereof.
3. The compound claimed in Claim 2, in which Ring A
is a phenylene group or a phenylene group substituted with a halogen atom; either one of R1 to R4 is an alkyl group of one to four carbon atoms, and the other groups of R1 to R4 are hydrogen atoms; R5 is a phenyl group or a phenyl group having a substituent selected from an alkyl group of one to three carbon atoms, a halogen atom, a trihalogenomethyl group and a nitro group; and -COOR6 is a free carboxyl group or a carboxyl group protected with an alkyl group of one to three carbon atoms, or a pharmaceutically acceptable salt thereof.
4 The compound claimed in Claim 2, in which Ring A
is a phenylene group or a phenylene group having a substituent selected from a fluorine atom and a chlorine atom; either one of R1 to R4 is a methyl group or an ethyl group, and the other groups are hydrogen atoms; R5 is a phenyl group or a phenyl group having a substituent selected from a methyl group, a fluorine atom, a chlorine atom, a bromine atom, a trifluoromethyl group and a nitro group; and -COOR6 is a free carboxyl group or a carboxyl group protected with an alkyl group of one to three carbon atoms, or a pharmaceutically acceptable salt thereof.
5. The compound as claimed in Claim 4, in which R5 is phenyl group, 4-fluorophenyl group, 4-chlorophenyl group, 4-bromophenyl group, 4-methylphenyl group, 4-trifluoromethyl group, or 4-nitrophenyl group, or a pharmaceutically acceptable salt thereof.
6. The compound as claimed in Claim 5, in which Ring A is phenylene group or a phenylene group substituted with a fluorine atom, or a pharmaceutically acceptable salt thereof.
7. The compound as claimed in Claim 6, in which Ring A is phenylene group; and R5 is a 4-chlorophenyl group, or a pharmaceutically acceptable salt thereof.
8. The compound as claimed in Claim 7, in which either one of R1 and R3 is a methyl group or an ethyl group, and the other group is a hydrogen atom; R2 and R4 are hydrogen atoms, or a pharmaceutically acceptable salt thereof.
9. The compound claimed in Claim 1, 2 or 3, in which -COOR6 is a free carboxyl group, or a pharmaceutically acceptable salt thereof.
10. The compound claimed in Claim 4, 5 or 6, in which -COOR6 is a free carboxyl group, or a pharmaceutically acceptable salt thereof.
11. The compound claimed in Claim 7 or 8, in which -COOR6 is a free carboxyl group, or a pharmaceutically acceptable salt thereof.
12. The compound as claimed in Claim 8, which is 4-[2-(4-chlorophenyl)sulfonylaminopropyl]phenoxyacetic acid, or a pharmaceutically acceptable salt thereof.
13. The compound as claimed in Claim 8, which is (-)-4-[2-(4-chlorophenyl)sulfonylaminopropyl]phenoxyacetic acid, or a pharmaceutically acceptable salt thereof.
14. A process for preparing a phenoxyacetic acid compound of the formula:

(1) wherein Ring A is a phenylene group or a phenylene group having 1 to 2 substituents selected from a lower alkyl group, a lower alkoxy group and a halogen atom; either one or two groups of R1, R2, R3 and R4 are a lower alkyl group, and the other groups are hydrogen atoms; R5 is a phenyl group or a phenyl group having 1 to 3 substi-tuents selected from a lower alkyl group, a halogen atom, a lower alkoxy group, a trihalogenomethyl group and a nitro group; and -COOR6 is a carboxyl group or a protected carboxyl group, or a pharmaceutically acceptable salt thereof, which comprises the step(s) of:
(A-i) condensing a phenol compound of the formula:

(II) wherein Ring A, R1, R2, R3, R4 and R5 are the same as defined above, or a salt thereof with an acetic acid derivative of the formula:
X1CH2COOR61 (III) wherein X1 is a reactive residue and -COOR61 is a carboxyl group or a protected carboxyl group, or (A-ii) condensing a phenyloxyacetic acid derivative of the formula:

(IV) wherein Y is an amino group, a protected amino group or a reactive residue and Ring A, R1, R2, R3, R4 and -COOR61 are the same as defined above, or a salt thereof with a benzenesulfonic acid compound of the formula:
R5SO2Z (V) wherein Z is a hydroxy group or a reactive residue when Y
is an amino group or a protected amino group, or Z is an amino group when Y is a reactive residue, and R5 is the same as defined above, (B) when -COOR61 is a protected carboxyl group and/or Y is a protected amino group, optionally removing said protecting group or groups therefrom, and (C) if required, further converting the product into a pharmaceutically acceptable salt thereof.
15. A pharmaceutical composition which comprises an effective amount of the compound claimed in Claims 1, 7 or 12 or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier therefor.
CA 543552 1986-08-06 1987-07-31 Phenoxyacetic acid derivatives and preparation thereof Expired - Fee Related CA1277675C (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
JP184693/1986 1986-08-06
JP18469386 1986-08-06
JP2685887 1987-02-06
JP26858/1987 1987-02-06

Publications (1)

Publication Number Publication Date
CA1277675C true CA1277675C (en) 1990-12-11

Family

ID=26364708

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 543552 Expired - Fee Related CA1277675C (en) 1986-08-06 1987-07-31 Phenoxyacetic acid derivatives and preparation thereof

Country Status (9)

Country Link
US (1) US4866196A (en)
KR (1) KR910007942B1 (en)
CN (1) CN1011780B (en)
CA (1) CA1277675C (en)
DE (1) DE3774795D1 (en)
DK (1) DK408987D0 (en)
EP (1) EP0255728B1 (en)
ES (1) ES2038630T3 (en)
FI (1) FI87769C (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8708233D0 (en) * 1987-04-07 1987-05-13 Smith Kline French Lab Pharmaceutically active compounds
JPH068274B2 (en) * 1988-01-19 1994-02-02 田辺製薬株式会社 Phenoxyacetic acid derivatives
EP0325245B1 (en) * 1988-01-19 1993-10-20 Tanabe Seiyaku Co., Ltd. Phenoxyacetic acid derivatives, preparation thereof, pharmaceutical compositions comprising them and use
JPH068275B2 (en) * 1988-02-04 1994-02-02 田辺製薬株式会社 Phenoxyacetic acid derivatives
DE3821540A1 (en) * 1988-06-25 1989-12-28 Boehringer Mannheim Gmbh New sulfonamides, processes for their production as well as those sulfonamide-containing drug
US5280043A (en) * 1988-10-10 1994-01-18 Smith Kline & French Laboratories Ltd. Sulphonamido containing phenylalkanoic acids as thromboxane A2 antagonists
JPH02169562A (en) * 1988-12-22 1990-06-29 Tanabe Seiyaku Co Ltd Glycine derivative and production thereof
US5084466A (en) * 1989-01-31 1992-01-28 Hoffmann-La Roche Inc. Novel carboxamide pyridine compounds which have useful pharmaceutical utility
US5256812A (en) * 1989-01-31 1993-10-26 Hoffmann-La Roche Inc. Carboxamides and sulfonamides
FR2645537B1 (en) * 1989-04-05 1994-03-04 Fabre Medicament Pierre New sulfonamide derivative of benzocycliques or benzoheterocyclic acids, their preparation and their therapeutic application
DE3942923A1 (en) * 1989-12-23 1991-06-27 Boehringer Mannheim Gmbh New phenoxyalkyl carboxylic acid amides, processes for their production, and these compounds containing drug
US5179105A (en) * 1990-10-16 1993-01-12 Terumo Kabushiki Kaisha Phenoxyacetic acid compounds, method for production thereof, and pharmaceutical preparations containing same
DE4037174A1 (en) * 1990-11-22 1992-05-27 Boehringer Mannheim Gmbh New sulfonamides, processes for their production and pharmaceuticals containing these compounds
JPH05125038A (en) * 1991-03-07 1993-05-21 Tanabe Seiyaku Co Ltd Phenoxyalkanoic acid derivative and its production
EP0562796A1 (en) * 1992-03-23 1993-09-29 Terumo Kabushiki Kaisha Phenoxyacetic acid compounds and medical preparations containing them
GB9702194D0 (en) * 1997-02-04 1997-03-26 Lilly Co Eli Sulphonide derivatives

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2809377A1 (en) * 1978-03-04 1979-09-13 Boehringer Mannheim Gmbh Phenoxyalkyl carboxylic acid derivatives, processes for their preparation and these compounds containing drug
DE3000377A1 (en) * 1980-01-07 1981-07-09 Boehringer Mannheim Gmbh New sulfonamides, processes for their preparation and these compounds containing drug
DE3535167A1 (en) * 1985-10-02 1987-04-09 Boehringer Mannheim Gmbh New sulfonyl-phenyl (alkyl) amines, process for their production as well as drug
DE3610643A1 (en) * 1986-03-29 1987-10-01 Boehringer Mannheim Gmbh New phenoxyalkyl carboxylic acid derivatives, methods for their manufacture, and these compounds containing drug

Also Published As

Publication number Publication date Type
US4866196A (en) 1989-09-12 grant
FI873413D0 (en) grant
ES2038630T3 (en) 1993-08-01 grant
FI873413A (en) 1988-02-07 application
EP0255728B1 (en) 1991-11-27 grant
FI87769C (en) 1993-02-25 grant
DE3774795D1 (en) 1992-01-09 grant
DK408987D0 (en) 1987-08-05 grant
EP0255728A3 (en) 1989-05-10 application
KR910007942B1 (en) 1991-10-04 grant
CN1011780B (en) 1991-02-27 application
EP0255728A2 (en) 1988-02-10 application
CN87105501A (en) 1988-02-17 application
FI87769B (en) 1992-11-13 application
FI873413A0 (en) 1987-08-06 application
DK408987A (en) 1988-02-07 application

Similar Documents

Publication Publication Date Title
US4569801A (en) Alkylsulfonamidophenylalkylamines
US4711903A (en) Phenolic thioethers as inhibitors of 5-lipoxygenase
US6162927A (en) Endothelin antagonists
Li et al. 1, 2-Diarylcyclopentenes as selective cyclooxygenase-2 inhibitors and orally active anti-inflammatory agents
US6506757B1 (en) Carboxylic acid derivatives and drugs containing the same as the active ingredient
EP0130795B1 (en) Carboxylic acid derivatives useful for inhibiting the degradation of cartilage
US5648370A (en) 7-(2-aminoethyl) benzothiazolones
US5792769A (en) Guanidino protease inhibitors
US4235885A (en) Inhibitors of mammalian collagenase
US5891909A (en) Amidinohydrazones as protease inhibitors
US4731382A (en) Lipoxygenase inhibitory phenylalkanohydroxamic acids
US4134991A (en) Derivatives of 2-(3-phenyl-2-aminopropionyloxy)-acetic acid
US5236921A (en) Arylalkylamines, process for preparing them and pharmaceutical compositions containing them
US3840597A (en) Substituted 2-phenoxy alkane-sulfonanilides
US3992441A (en) Sulfamylbenzoic acids
Lindberg et al. Inhibitors of neuronal monoamine uptake. 2. Selective inhibition of 5-hydroxytryptamine uptake by. alpha.-amino acid esters of phenethyl alcohols
WO2002057233A1 (en) Mch antagonists and their use in the treatment of obesity
US3383411A (en) 4-alkanoylphenoxy-alkanoic acids
WO1997043305A1 (en) Inhibitors of picornavirus 3c proteases and methods for their use and preparation
WO1998042659A2 (en) Aryl- or heteroarylsulfonamide substituted hydroxamic acid derivates, process for their preparation and their use as pharmaceuticals
WO2004089885A1 (en) Novel compounds
WO2007125351A1 (en) Pyrimidine derivatives for the treatment of amyloid-related diseases
EP0348155A1 (en) Quinoline derivatives as antagonists of leukotriene D4, compositions containing the same and processes for their preparation
WO1997005865A1 (en) C-proteinase inhibitors for the treatment of disorders related to the overproduction of collagen
US4211783A (en) Hypolipidemic and antiatherosclerotic novel 4-(aralkyl- and heteroarylalkylamino)phenyl compounds

Legal Events

Date Code Title Description
MKLA Lapsed